id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1978-N-0018-0819,FDA,FDA-1978-N-0018,JJCI Ski Study (SPF 50+) from Johnson & Johnson Consumer Inc.,Supporting & Related Material,Background Material,2016-11-30T05:00:00Z,2016,11,,,2016-11-30T21:43:34Z,,0,0,09000064823ba752
FDA-1978-N-0018-0818,FDA,FDA-1978-N-0018,Formal Meeting Request from Johnson & Johnson Consumer Inc. to FDA CDER Office of Drug Evaluation,Other,Request,2016-11-23T05:00:00Z,2016,11,2016-11-23T05:00:00Z,,2016-11-30T20:07:19Z,,0,0,09000064823ba751
FDA-1978-N-0018-0817,FDA,FDA-1978-N-0018,Letter from FDA CDER for Announcement of Meeting with PASS Coalition,Other,Letter(s),2016-10-21T04:00:00Z,2016,10,2016-10-21T04:00:00Z,,2016-10-21T14:18:28Z,,0,0,0900006482330e53
FDA-1978-N-0018-0816,FDA,FDA-1978-N-0018,Letter from FDA CDER for Announcement of Meeting,Other,Letter(s),2016-10-07T04:00:00Z,2016,10,2016-10-07T04:00:00Z,,2016-10-07T11:59:06Z,,0,0,09000064822a11d1
FDA-1978-N-0018-0815,FDA,FDA-1978-N-0018,Background Material Specific Questions for FDA from Holland&Knight,Supporting & Related Material,Background Material,2016-09-15T04:00:00Z,2016,9,,,2016-09-15T19:23:14Z,,0,0,090000648221463c
FDA-1978-N-0018-0814,FDA,FDA-1978-N-0018,Request for Meeting from PASS Coalition (Holland & Knight),Other,Request,2016-09-08T04:00:00Z,2016,9,2016-09-08T04:00:00Z,,2016-09-08T18:14:44Z,,0,0,09000064821e3bbf